Metformin is associated with reduced COVID-19 severity in patients with prediabetes

Mostrar otras versiones (1)

AIMS: Studies suggest that metformin is associated with reduced COVID-19 severity in individuals with diabetes compared to other antihyperglycemics. We assessed if metformin is associated with reduced incidence of severe COVID-19 for patients with prediabetes or polycystic ovary syndrome (PCOS), com...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Lauren E., Casiraghi, Elena, Laraway, Bryan, Coleman, Ben, Blau, Hannah, Zaman, Adnin, Harris, Nomi L., Wilkins, Kenneth, Antony, Blessy, Gargano, Michael, Valentini, Giorgio, Sahner, David, Haendel, Melissa, Robinson, Peter N., Bramante, Carolyn, Reese, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Scientific Publishers 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663381/
https://www.ncbi.nlm.nih.gov/pubmed/36400170
http://dx.doi.org/10.1016/j.diabres.2022.110157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663381/
https://www.ncbi.nlm.nih.gov/pubmed/36400170
http://dx.doi.org/10.1016/j.diabres.2022.110157

Ejemplares similares